PMHNP EXAM vc
Exam Solution vc
Final Exam Test Questions 2026 A+ GRADE ASSURED CO
vc vc vc vc vc vc vc vc
MPLETE SOLUTIONS AND VERIFIED ANSWERS (A97B3) vc vc vc vc vc
QUESTION 1 vc
Question 18: Christine is a 9-year- vc vc vc vc vc
old female who presents for care after having been placed in the local foster care system.
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
She has been in and out of foster care for the last 4 years after her parents were killed i
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
n an automobile accident. Christine has been placed in a variety of homes and residentia
vc vc vc vc vc vc vc vc vc vc vc vc vc vc
l care facilities. The PMHNP recognizes that Christine is at high risk for:
vc vc vc vc vc vc vc vc vc vc vc vc
ANSWER
A. Dissociative disorders
vc vc
B. Post-traumatic stress disorder
vc vc vc
C. Impulse-control disorder
vc vc
D. Attachment disorder
vc vc
QUESTION 2 vc
Question 2: Debi is a 15-year- vc vc vc vc vc
old girl who is currently being treated for depression. Her parents have been very proact
vc vc vc vc vc vc vc vc vc vc vc vc vc vc
ive and involved in her care, and Debi has achieved remission 2 months after beginning t
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
reatment with a combination of pharmacotherapy and cognitive behavioral therapy. Whi
vc vc vc vc vc vc vc vc vc vc
le counseling Debi's parents about important issues in management, the PMHNP advises
vc vc vc vc vc vc vc vc vc vc vc vc
that:
ANSWER
A. There is a > 50% likelihood that Debi's younger sibling will develop depressive symptoms
vc vc vc vc vc vc vc vc vc vc vc vc vc vc
B. The mean length of major depressive episode in adolescents is 4 months
vc vc vc vc vc vc vc vc vc vc vc vc
C. 20 to 40% of adolescents who have major depressive disorder will develop bipolar I within 5 years
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
D. Adolescent-onset depression typically need long-
vc vc vc vc vc
term pharmacologic management to prevent relapses
vc vc vc vc vc
QUESTION 3 vc
Agomelatine
,ANSWER
Brand: Valdoxan -Melatonin multimodal (Mel-MM) -
vc vc vc vc vc
Agonist at melatonergic 1 and melatonergic 2 receptors -Antagonist at 5HT2C receptors -
vc vc vc vc vc vc vc vc vc vc vc vc
Not FDA approved: Rx for Depression, Generalized anxiety disorder -
vc vc vc vc vc vc vc vc vc
Initial 25 mg/day at bedtime; after 2 weeks can increase to 50 mg/day at bedtime
vc vc vc vc vc vc vc vc vc vc vc vc vc vc
QUESTION 4 vc
Amitriptyline (Elavil) vc
ANSWER
Tricyclic antidepressant. vc
QUESTION 5 vc
Aripiprazole (Abilify) vc
ANSWER
Treatment for depression. Atypical antipsychotic. "Dopamine stabilizer". Dopamine receptor antagonist i
vc vc vc vc vc vc vc vc vc vc
n high concentration and also stimulates increase of dopamine in low concentrations. Side effects: insom
vc vc vc vc vc vc vc vc vc vc vc vc vc vc
nia, akathisia.
vc
QUESTION 6 vc
Brexpiprazole (Rexulti) vc
ANSWER
Treatment for depression. Atypical antipsychotic
vc vc vc vc
QUESTION 7 vc
Bupropion (Wellbutrin) vc
ANSWER
Antidepressant and smoking cessation aid, It can treat depression and help people quit smoking. It can a
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
lso prevent depression caused by seasonal affective disorder (SAD).
vc vc vc vc vc vc vc vc
QUESTION 8 vc
Citalopram (Celexa) vc
ANSWER
Antidepressant, SSRI: 20-40 mg qd. vc vc vc vc
, QUESTION 9 vc
Cyamemazine (Tercian) vc
ANSWER
Treatment for depression. -Known as cyamepromazine -
vc vc vc vc vc vc
Typical antipsychotic drug of the phenothiazine class. -Treatment for schizophrenia and psychosis-
vc vc vc vc vc vc vc vc vc vc vc
associated anxiety -Behaves like an atypical antipsychotic, due to its potent anxiolytic effects (5-
vc vc vc vc vc vc vc vc vc vc vc vc vc
HT2C) and lack of extrapyramidal side effects (5-HT2A). -
vc vc vc vc vc vc vc vc
Conventional antipsychotic (neuroleptic, phenothiazine, dopamine 2 antagonist, serotonin dopamine ant
vc vc vc vc vc vc vc vc vc
agonist) -Commonly Prescribed for (not FDA approved): -Schizophrenia -
vc vc vc vc vc vc vc vc
Anxiety associated with psychosis (short-term) -
vc vc vc vc vc
Anxiety associated with nonpsychotic disorders, including mood disorders and personality disorders (sh
vc vc vc vc vc vc vc vc vc vc vc
ort-term) -Severe depression -Bipolar disorder -Other psychotic disorders -
vc vc vc vc vc vc vc vc
Acute agitation/aggression (injection) -Benzodiazepine withdrawal
vc vc vc vc
QUESTION 10 vc
Desiprimine (Norpramine) vc
ANSWER
Treats depression Brand: Norpramin -TCA -Norepinephrine noradrenaline reuptake inhibitor. -
vc vc vc vc vc vc vc vc vc
FDA approved for treating depression. -Off-
vc vc vc vc vc
label: Anxiety, Insomnia, Neuropathic pain/chronic pain, Treatment-resistant depression. -
vc vc vc vc vc vc vc vc
More potent inhibitor of norepinephrine reuptake pump than serotonin reuptake pump (serotonin trans
vc vc vc vc vc vc vc vc vc vc vc vc
porter). -May have immediate effects in treating insomnia or anxiety. -If it is not working within 6-
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
8 weeks for depression, it may require a dosage increase or it may not work at all -100-
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
200 mg/day (for depression) 50-150 mg/day (for chronic pain).
vc vc vc vc vc vc vc vc
QUESTION 11 vc
Desvenlafaxine (Pristiq) vc
ANSWER
Dual serotonin and norepinephrine reuptake inhibitor-often classified as an antidepressant. -
vc vc vc vc vc vc vc vc vc vc
FDA approved to tx MDD. -Off-
vc vc vc vc vc
label: Vasomotor sx's, fibromyalgia, GAD, Social Anx d/o, panic d/o, PTSD, PMDD -
vc vc vc vc vc vc vc vc vc vc vc vc
Dopamine is inactivated by norepinephrine reuptake in frontal cortex (which lack dopamine transporter
vc vc vc vc vc vc vc vc vc vc vc vc
s) med can increase dopamine neurotransmission in this part of the brain -
vc vc vc vc vc vc vc vc vc vc vc vc
QUESTION 12 vc
Risperidone (Risperdal) vc
ANSWER
Exam Solution vc
Final Exam Test Questions 2026 A+ GRADE ASSURED CO
vc vc vc vc vc vc vc vc
MPLETE SOLUTIONS AND VERIFIED ANSWERS (A97B3) vc vc vc vc vc
QUESTION 1 vc
Question 18: Christine is a 9-year- vc vc vc vc vc
old female who presents for care after having been placed in the local foster care system.
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
She has been in and out of foster care for the last 4 years after her parents were killed i
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
n an automobile accident. Christine has been placed in a variety of homes and residentia
vc vc vc vc vc vc vc vc vc vc vc vc vc vc
l care facilities. The PMHNP recognizes that Christine is at high risk for:
vc vc vc vc vc vc vc vc vc vc vc vc
ANSWER
A. Dissociative disorders
vc vc
B. Post-traumatic stress disorder
vc vc vc
C. Impulse-control disorder
vc vc
D. Attachment disorder
vc vc
QUESTION 2 vc
Question 2: Debi is a 15-year- vc vc vc vc vc
old girl who is currently being treated for depression. Her parents have been very proact
vc vc vc vc vc vc vc vc vc vc vc vc vc vc
ive and involved in her care, and Debi has achieved remission 2 months after beginning t
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
reatment with a combination of pharmacotherapy and cognitive behavioral therapy. Whi
vc vc vc vc vc vc vc vc vc vc
le counseling Debi's parents about important issues in management, the PMHNP advises
vc vc vc vc vc vc vc vc vc vc vc vc
that:
ANSWER
A. There is a > 50% likelihood that Debi's younger sibling will develop depressive symptoms
vc vc vc vc vc vc vc vc vc vc vc vc vc vc
B. The mean length of major depressive episode in adolescents is 4 months
vc vc vc vc vc vc vc vc vc vc vc vc
C. 20 to 40% of adolescents who have major depressive disorder will develop bipolar I within 5 years
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
D. Adolescent-onset depression typically need long-
vc vc vc vc vc
term pharmacologic management to prevent relapses
vc vc vc vc vc
QUESTION 3 vc
Agomelatine
,ANSWER
Brand: Valdoxan -Melatonin multimodal (Mel-MM) -
vc vc vc vc vc
Agonist at melatonergic 1 and melatonergic 2 receptors -Antagonist at 5HT2C receptors -
vc vc vc vc vc vc vc vc vc vc vc vc
Not FDA approved: Rx for Depression, Generalized anxiety disorder -
vc vc vc vc vc vc vc vc vc
Initial 25 mg/day at bedtime; after 2 weeks can increase to 50 mg/day at bedtime
vc vc vc vc vc vc vc vc vc vc vc vc vc vc
QUESTION 4 vc
Amitriptyline (Elavil) vc
ANSWER
Tricyclic antidepressant. vc
QUESTION 5 vc
Aripiprazole (Abilify) vc
ANSWER
Treatment for depression. Atypical antipsychotic. "Dopamine stabilizer". Dopamine receptor antagonist i
vc vc vc vc vc vc vc vc vc vc
n high concentration and also stimulates increase of dopamine in low concentrations. Side effects: insom
vc vc vc vc vc vc vc vc vc vc vc vc vc vc
nia, akathisia.
vc
QUESTION 6 vc
Brexpiprazole (Rexulti) vc
ANSWER
Treatment for depression. Atypical antipsychotic
vc vc vc vc
QUESTION 7 vc
Bupropion (Wellbutrin) vc
ANSWER
Antidepressant and smoking cessation aid, It can treat depression and help people quit smoking. It can a
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
lso prevent depression caused by seasonal affective disorder (SAD).
vc vc vc vc vc vc vc vc
QUESTION 8 vc
Citalopram (Celexa) vc
ANSWER
Antidepressant, SSRI: 20-40 mg qd. vc vc vc vc
, QUESTION 9 vc
Cyamemazine (Tercian) vc
ANSWER
Treatment for depression. -Known as cyamepromazine -
vc vc vc vc vc vc
Typical antipsychotic drug of the phenothiazine class. -Treatment for schizophrenia and psychosis-
vc vc vc vc vc vc vc vc vc vc vc
associated anxiety -Behaves like an atypical antipsychotic, due to its potent anxiolytic effects (5-
vc vc vc vc vc vc vc vc vc vc vc vc vc
HT2C) and lack of extrapyramidal side effects (5-HT2A). -
vc vc vc vc vc vc vc vc
Conventional antipsychotic (neuroleptic, phenothiazine, dopamine 2 antagonist, serotonin dopamine ant
vc vc vc vc vc vc vc vc vc
agonist) -Commonly Prescribed for (not FDA approved): -Schizophrenia -
vc vc vc vc vc vc vc vc
Anxiety associated with psychosis (short-term) -
vc vc vc vc vc
Anxiety associated with nonpsychotic disorders, including mood disorders and personality disorders (sh
vc vc vc vc vc vc vc vc vc vc vc
ort-term) -Severe depression -Bipolar disorder -Other psychotic disorders -
vc vc vc vc vc vc vc vc
Acute agitation/aggression (injection) -Benzodiazepine withdrawal
vc vc vc vc
QUESTION 10 vc
Desiprimine (Norpramine) vc
ANSWER
Treats depression Brand: Norpramin -TCA -Norepinephrine noradrenaline reuptake inhibitor. -
vc vc vc vc vc vc vc vc vc
FDA approved for treating depression. -Off-
vc vc vc vc vc
label: Anxiety, Insomnia, Neuropathic pain/chronic pain, Treatment-resistant depression. -
vc vc vc vc vc vc vc vc
More potent inhibitor of norepinephrine reuptake pump than serotonin reuptake pump (serotonin trans
vc vc vc vc vc vc vc vc vc vc vc vc
porter). -May have immediate effects in treating insomnia or anxiety. -If it is not working within 6-
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
8 weeks for depression, it may require a dosage increase or it may not work at all -100-
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc
200 mg/day (for depression) 50-150 mg/day (for chronic pain).
vc vc vc vc vc vc vc vc
QUESTION 11 vc
Desvenlafaxine (Pristiq) vc
ANSWER
Dual serotonin and norepinephrine reuptake inhibitor-often classified as an antidepressant. -
vc vc vc vc vc vc vc vc vc vc
FDA approved to tx MDD. -Off-
vc vc vc vc vc
label: Vasomotor sx's, fibromyalgia, GAD, Social Anx d/o, panic d/o, PTSD, PMDD -
vc vc vc vc vc vc vc vc vc vc vc vc
Dopamine is inactivated by norepinephrine reuptake in frontal cortex (which lack dopamine transporter
vc vc vc vc vc vc vc vc vc vc vc vc
s) med can increase dopamine neurotransmission in this part of the brain -
vc vc vc vc vc vc vc vc vc vc vc vc
QUESTION 12 vc
Risperidone (Risperdal) vc
ANSWER